SCHEMBL19082121

SCHEMBL19082121

c1ccc2c(-c3c4ccccc4c(-c4cc5c(sc6ccc7ccccc7c65)c5sc6ccccc6c45)c4ccccc34)cccc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 2/20 0.37
NQO1 P15559 1/20 0.37
PTPN1 P18031 3/20 0.36
MAP3K9 P80192 4/20 0.35
MAP3K11 Q16584 4/20 0.35
ALOX5 P09917 1/20 0.34
CDK4 P11802 1/20 0.32
CCND1 P24385 1/20 0.32
MAPT P10636 2/20 0.32
DUSP3 P51452 2/20 0.32
MEN1 O00255 1/20 0.32
POLB P06746 1/20 0.32
BLM P54132 1/20 0.32
PTPN5 P54829 1/20 0.32
KMT2A Q03164 1/20 0.32
PTPN11 Q06124 1/20 0.32
MCL1 Q07820 1/20 0.32
CTDSP1 Q9GZU7 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
NTRK1 P04629 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082250 0.92 ALOX5 (0.36) NQO2NQO1PTPN1MAP3K9MAP3K11
SCHEMBL19082386 0.90 ALOX5 (0.37) NQO2NQO1PTPN1MAP3K9MAP3K11
SCHEMBL17944593 0.89 ALOX5 (0.40) NQO2NQO1PTPN1MAP3K9MAP3K11
SCHEMBL19082194 0.89 PTPN1 (0.37) NQO2NQO1PTPN1MAP3K9MAP3K11
SCHEMBL19082333 0.85 PTPN1 (0.36) NQO2NQO1PTPN1MAP3K9MAP3K11
SCHEMBL19082116 0.85 NQO1 (0.36) NQO2NQO1PTPN1MAP3K9MAP3K11
SCHEMBL19082371 0.85 NQO1 (0.36) NQO2NQO1PTPN1MAP3K9MAP3K11
SCHEMBL19082172 0.85 PTPN1 (0.34) NQO2NQO1PTPN1ALOX5
SCHEMBL19082365 0.85 NQO2 (0.37) NQO2NQO1PTPN1MAP3K9MAP3K11
SCHEMBL17944235 0.84 ALOX5 (0.38) NQO2NQO1PTPN1MAP3K9MAP3K11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 NQO2 2592/4885NQO1 576/4885PTPN1 4695/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 NQO2 2592/4885NQO1 576/4885PTPN1 4695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.